Re: Adaptive therapy for androgen-independent prostate cancer: a randomized selection trial of four regimens.
Publication
, Journal Article
Armstrong, AJ; Garrett-Mayer, EL; Eisenberger, M
Published in: J Natl Cancer Inst
May 7, 2008
Duke Scholars
Published In
J Natl Cancer Inst
DOI
EISSN
1460-2105
Publication Date
May 7, 2008
Volume
100
Issue
9
Start / End Page
681 / 682
Location
United States
Related Subject Headings
- Treatment Outcome
- Taxoids
- Survival Analysis
- Selection Bias
- Randomized Controlled Trials as Topic
- Prostatic Neoplasms
- Prednisone
- Oncology & Carcinogenesis
- Mitoxantrone
- Male
Citation
APA
Chicago
ICMJE
MLA
NLM
Armstrong, A. J., Garrett-Mayer, E. L., & Eisenberger, M. (2008). Re: Adaptive therapy for androgen-independent prostate cancer: a randomized selection trial of four regimens. J Natl Cancer Inst, 100(9), 681–682. https://doi.org/10.1093/jnci/djn104
Armstrong, Andrew J., Elizabeth L. Garrett-Mayer, and Mario Eisenberger. “Re: Adaptive therapy for androgen-independent prostate cancer: a randomized selection trial of four regimens.” J Natl Cancer Inst 100, no. 9 (May 7, 2008): 681–82. https://doi.org/10.1093/jnci/djn104.
Armstrong AJ, Garrett-Mayer EL, Eisenberger M. Re: Adaptive therapy for androgen-independent prostate cancer: a randomized selection trial of four regimens. J Natl Cancer Inst. 2008 May 7;100(9):681–2.
Armstrong, Andrew J., et al. “Re: Adaptive therapy for androgen-independent prostate cancer: a randomized selection trial of four regimens.” J Natl Cancer Inst, vol. 100, no. 9, May 2008, pp. 681–82. Pubmed, doi:10.1093/jnci/djn104.
Armstrong AJ, Garrett-Mayer EL, Eisenberger M. Re: Adaptive therapy for androgen-independent prostate cancer: a randomized selection trial of four regimens. J Natl Cancer Inst. 2008 May 7;100(9):681–682.
Published In
J Natl Cancer Inst
DOI
EISSN
1460-2105
Publication Date
May 7, 2008
Volume
100
Issue
9
Start / End Page
681 / 682
Location
United States
Related Subject Headings
- Treatment Outcome
- Taxoids
- Survival Analysis
- Selection Bias
- Randomized Controlled Trials as Topic
- Prostatic Neoplasms
- Prednisone
- Oncology & Carcinogenesis
- Mitoxantrone
- Male